Literature DB >> 10748180

Identification and characterization of cell lines with a defect in a post-adsorption stage of Sendai virus-mediated membrane fusion.

A Eguchi1, T Kondoh, H Kosaka, T Suzuki, H Momota, A Masago, T Yoshida, H Taira, A Ishii-Watabe, J Okabe, J Hu, N Miura, S Ueda, Y Suzuki, T Taki, T Hayakawa, M Nakanishi.   

Abstract

In the early stage of infection, Sendai virus delivers its genome into the cytoplasm by fusing the viral envelope with the cell membrane. Although the adsorption of virus particles to cell surface receptors has been characterized in detail, the ensuing complex process that leads to the fusion between the lipid bilayers remains mostly obscure. In the present study, we identified and characterized cell lines with a defect in the Sendai virus-mediated membrane fusion, using fusion-mediated delivery of fragment A of diphtheria toxin as an index. These cells, persistently infected with the temperature-sensitive variant Sendai virus, had primary viral receptors indistinguishable in number and affinity from those of parental susceptible cells. However, they proved to be thoroughly defective in the Sendai virus-mediated membrane fusion. We also found that viral HN protein expressed in the defective cells was responsible for the interference with membrane fusion. These results suggested the presence of a previously uncharacterized, HN-dependent intermediate stage in the Sendai virus-mediated membrane fusion.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10748180     DOI: 10.1074/jbc.M910004199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Evidence that Receptor Destruction by the Sendai Virus Hemagglutinin-Neuraminidase Protein Is Responsible for Homologous Interference.

Authors:  Hideo Goto; Keisuke Ohta; Yusuke Matsumoto; Natsuko Yumine; Machiko Nishio
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

2.  Advanced feeder-free generation of induced pluripotent stem cells directly from blood cells.

Authors:  Ras Trokovic; Jere Weltner; Ken Nishimura; Manami Ohtaka; Mahito Nakanishi; Veikko Salomaa; Anu Jalanko; Timo Otonkoski; Aija Kyttälä
Journal:  Stem Cells Transl Med       Date:  2014-10-29       Impact factor: 6.940

3.  Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming.

Authors:  Ken Nishimura; Masayuki Sano; Manami Ohtaka; Birei Furuta; Yoko Umemura; Yoshiro Nakajima; Yuzuru Ikehara; Toshihiro Kobayashi; Hiroaki Segawa; Satoko Takayasu; Hideyuki Sato; Kaori Motomura; Eriko Uchida; Toshie Kanayasu-Toyoda; Makoto Asashima; Hiromitsu Nakauchi; Teruhide Yamaguchi; Mahito Nakanishi
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

4.  Studying vertebrate topoisomerase 2 function using a conditional knockdown system in DT40 cells.

Authors:  Mark Johnson; Hui Hui Phua; Sophia C Bennett; Jennifer M Spence; Christine J Farr
Journal:  Nucleic Acids Res       Date:  2009-06-03       Impact factor: 16.971

Review 5.  Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine.

Authors:  Mahito Nakanishi; Makoto Otsu
Journal:  Curr Gene Ther       Date:  2012-10       Impact factor: 4.391

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.